https://www.nfcr.org/blog/nfcr-congratulates-gcar-on-its-new-partnership-gbm-agile-expansion-2024/
NFCR Congratulates GCAR on GBM AGILE Expansion
Dec 2, 2025 - NFCR Congratulates GCAR on expanding GBM AGILE to accelerate treatment options for pancreatic cancer patients.
gbm agilecongratulatesexpansion
https://scholars.duke.edu/publication/1657107
Scholars@Duke publication: LTBK-02. EVALUATION OF PAXALISIB IN GBM AGILE PHASE 3 REGISTRATION...
gbm agilescholarsdukepublicationevaluation
https://www.mdanderson.org/patients-family/diagnosis-treatment/clinical-trials/clinical-trials-index/clinical-trials-detail.ID2019-0216.html
GBM AGILE Global Adaptive Trial Master Protocol: An International, Seamless Phase II/III Response...
Glioblastoma (GBM) adaptive, global, innovative learning environment (GBM AGILE) is an international, seamless Phase II/III response adaptive randomization...
gbm agilephase iiglobaladaptivetrial
https://newdev.afcr.org/en/2018/08/24/gbm-agile-revolutionary-clinical-research-model-to-defeat-deadliest-brain-cancer/gbm-agile-logo/
gbm agile - Asian Fund for Cancer Research
gbm agilecancer researchasianfund
https://cancer.osu.edu/for-patients-and-caregivers/learn-about-cancers-and-treatments/innovation-at-the-james/clinical-trials/find-a-clinical-trial/gbm-agile-global-adaptive-trial-master-protocol
GBM AGILE Global Adaptive Trial Master Protocol
GBM AGILE Global Adaptive Trial Master Protocol
gbm agileglobaladaptivetrialmaster
https://clinicaltrials.med.nyu.edu/cancer/clinicaltrial/1546/gbm-agile-trial/?qd=39010029
GBM AGILE TRIAL | NYU Langone Health
New life-saving treatments for Glioblastoma in clinical trial on GBM AGILE TRIAL
nyu langone healthgbm agiletrial